118525-40-9

  • Product Name:Icaritin
  • Molecular Formula:C21H20O6
  • Purity:99%
  • Molecular Weight:
Inquiry

Product Details;

CasNo: 118525-40-9

Molecular Formula: C21H20O6

Henan Wentao Chemical Product Co., Ltd. is a quality supplier and manufacturer of Icaritin . You can buy high quality, wholesale price Icaritin 118525-40-9 here. Contact us.

 

Icaritin 118525-40-9 In Bulk Supply with Wholesale Price

  • Molecular Formula:C21H20O6
  • Molecular Weight:368.386
  • Vapor Pressure:3.82E-14mmHg at 25°C 
  • Melting Point:239 °C 
  • Refractive Index:1.656 
  • Boiling Point:581.992 °C at 760 mmHg 
  • PKA:6.44±0.40(Predicted) 
  • Flash Point:206.679 °C 
  • PSA:100.13000 
  • Density:1.36 g/cm3 
  • LogP:4.09410 

118525-40-9 Usage

Lcaritin is Yellow crystalline powder, soluble in methanol, ethanol, DMSO and other organic solvents, derived from epimedium. Icaritin is a compound derived from the Epimedium plant, also known as horny goat weed. It has been studied for its potential health benefits, including its ability to promote bone health, improve cognitive function, and even exhibit anti-cancer properties. However, further research is still needed to fully understand its effects on human health. They also have significant antiangiogenesis properties, inhibiting or eliminating entirely the development of new malignant cells. Icaritin has been used in trials studying the treatment of Solid Tumors, Metastatic Breast Cancer, and Hepatocellular Carcinoma (HCC).

InChI:InChI=1/C21H20O6/c1-11(2)4-9-14-15(22)10-16(23)17-18(24)19(25)20(27-21(14)17)12-5-7-13(26-3)8-6-12/h4-8,10,22-23,25H,9H2,1-3H3

118525-40-9 Relevant articles

Synthesis of icariin from kaempferol through regioselective methylation and para-Claisen - Cope rearrangement

Mei, Qinggang,Wang, Chun,Zhao, Zhigang,Yuan, Weicheng,Zhang, Guolin

, p. 1220 - 1225 (2015)

The hemisynthesis of the naturally occurring bioactive flavonoid glycoside icariin (1) has been accomplished in eleven steps with 7% overall yield from kaempferol. The 4?-OH methylation of kaempferol, the 8-prenylation of 3-O-methoxymethyl-4?-O-methyl-5- O-prenyl-7-O-benzylkaempferol (8) via para-Claisen-Cope rearrangement catalyzed by Eu(fod)3 in the presence of NaHCO3 , and the glycosylation of icaritin (3) are the key steps.

A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells

Huang, Xin,Zhu, Danyan,Lou, Yijia

, p. 26 - 36 (2007)

Icariin and icaritin with prenyl group have been demonstrated for their selective estrogen receptor modulating activities. These findings suggested a novel anticancer efficacy of icaritin mediated selectively via induction of cell cycle arrest but not associated with estrogen receptors in PC-3 cells.

Magnesium dicarboxylates promote the prenylation of phenolics that is extended to the total synthesis of icaritin

Fu, Xuewen,Lu, Xiaoxia,Wang, Chun,Wen, Yongju,Xiong, Wei,Zhang, Guolin,Zhang, Jichao

, p. 1117 - 1124 (2022/02/16)

The prenylation of phenolic substrates promoted by magnesium dicarboxylates was developed. An investigation of the scope demonstrated that substrates with electron-donating group(s) gave better yields than those with electron-withdrawing group(s). Althoug

Convenient and efficient total synthesis method for icaritin and derivatives of icaritin

-

Paragraph 0063; 0084-0088, (2020/02/06)

The invention belongs to the field of natural medicine synthesis and particularly relates to a convenient and efficient total synthesis method for icaritin and derivatives of icaritin. The total synthesis method provided by the invention is mild in condition, convenient to operate, high intotal yield and suitable for mass production of the isopentenyl flavone compound.

ANALOGS OF THE NATURAL PRODUCT ICARIIN

-

Paragraph 00168; 00192, (2020/03/02)

Provided herein are analogs of the natural product icariin represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. The analogs can be used to modulate (e.g., inhibit, such as by competitive inhibition) PDE5 and thereby treat a wide range of PDE5- mediated diseases, including cardiovascular, gastrointestinal, pulmonary, musculoskeletal, neurological and reproductive diseases. Also provided herein are compositions and methods including compounds of Structural Formula (I).

118525-40-9 Process route

epimedium koreanum Nakai, leaves; 1-butanol-ether-hexane-methanol extract of

epimedium koreanum Nakai, leaves; 1-butanol-ether-hexane-methanol extract of

icaritin
118525-40-9

icaritin

icariside II
113558-15-9

icariside II

3-hydroxy-7-O-β-glucose-8-prenyl-4'-methoxychrysin
56725-99-6

3-hydroxy-7-O-β-glucose-8-prenyl-4'-methoxychrysin

Conditions
Conditions Yield
With hydrogenchloride; methanol; water; at 80 ℃; for 8h; Product distribution / selectivity; Heating / reflux;
 
With sodium methylate; In pyridine; at 80 ℃; for 8h; Product distribution / selectivity; Heating / reflux;
 
With acetic acid; β-glucuronidase; naringinase; hesperidinase; β-galactosidase; cellulase; amyloglucosidase; at 37 ℃; for 48h; pH=4.5; Product distribution / selectivity;
 
epimedium koreanum Nakai, leaves; 1-butanol-ether-hexane-methanol extract of; With water; at 121 ℃; for 0.5h;
at 30 ℃; for 120h; Product distribution / selectivity;
 
7-(benzyloxy)-3,5-dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-4H-chromen-4-one

7-(benzyloxy)-3,5-dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-en-1-yl)-4H-chromen-4-one

icaritin
118525-40-9

icaritin

Conditions
Conditions Yield
With cyclohexa-1,4-diene; palladium 10% on activated carbon; In methanol; at 20 ℃; for 2h;
86%
With cyclohexa-1,4-diene; palladium 10% on activated carbon; In methanol; at 20 ℃; for 2h;
84%

118525-40-9 Upstream products

  • 118525-35-2
    118525-35-2

    sagittatoside A

  • 489-32-7
    489-32-7

    icariin

  • 110623-72-8
    110623-72-8

    4'-methoxy-5-hydroxy-8-3,3-dimethylallylflavone 3-O-β-D-glucopyranosyl(1<*>2)α-L-rhamnopyranoside-7-O-β-D-glucopyranoside

  • 100-09-4
    100-09-4

    4-methoxybenzoic acid

118525-40-9 Downstream products

  • 50-99-7
    50-99-7

    2,3,4,5,6-pentahydroxy-hexanal

  • 28610-31-3
    28610-31-3

    8-prenylkaempferol

  • 1186604-06-7
    1186604-06-7

    3,7-dimethanesulfonyl-8-prenyl-4'-methoxychrysin